Lessee, Operating Lease, Liability, Undiscounted Excess Amount of POINT Biopharma Global Inc. from 30 Jun 2023 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
POINT Biopharma Global Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 30 Jun 2023 to 30 Sep 2023.
  • POINT Biopharma Global Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 30 Sep 2023 was $2,385,189.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

POINT Biopharma Global Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $2,385,189 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $30,616 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.